ONEBIO LABS / RESEARCH INFORMATION
TB-500
Research Peptide | Thymosin Beta-4-Related Material
Technical specifications
| Classification | Thymosin beta-4-related research peptide |
|---|---|
| Exact identity | Confirm whether full thymosin beta-4 or fragment is supplied |
| Sequence | Refer to batch COA |
| Form | Lyophilised peptide |
| Identity / purity | Refer to batch-specific analytical documentation |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
The term TB-500 is used inconsistently across suppliers. ONE BIOLABS should publish the exact sequence and molecular identity shown on its batch COA rather than assume equivalence with full-length thymosin beta-4.
01 / PRODUCT INFORMATION
Product description
TB-500 is a commercial research name used for thymosin beta-4-related peptide material. Thymosin beta-4 biology is studied in actin regulation, cell migration, angiogenesis and tissue-response models.
02 / RESEARCH CONTEXT
Research overview
Research areas: Actin dynamics; cell migration; angiogenesis; wound-response and tissue-repair models.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.